company
as of 2026-07-01Yale University
at a glance
83 trials sponsored · 60 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
60 assets
AripiprazoleCannabidiolOlanzapineQuetiapineRisperidoneZiprasidone1-hertz Repetitive Transcranial Magnetic Stimulation11C-EMO - A Novel PET Radiotracer for Muscarinic M1 ReceptorAcamprosateActive 1-Hertz Repetitive transcranial magnetic stimulationActive Delta-9-THCActive DronabinolActive PregnenoloneActive rTMS (20Hz)Alpha Lipoic AcidAssertive case managementAtomoxetine (Strattera™)Benefits ManagementBupropionCVL-562 (PF-06412562) 1 mgCVL-562 (PF-06412562) 15 mgCVL-562 (PF-06412562) 25 mgCVL-562 (PF-06412562) 4 mgCognitive Behavioral Group TherapyCognitive RemediationCognitive Retraining (CRT)Cognitive retrainingCommunity integration (CI)Computer-Based Cognitive Enhancement Training ProgramCoordinated Specialty Care (CSC)D-serineDelta-9-THCDelta-9-THC Medium DoseDelta-9-THC Very Low DoseDexmedetomidine HydrochlorideEarly Detection (ED)GalantamineGuanfacineIllness Management and RecoveryIllness management recovery (IMR)KetamineKetamine and NicotineLow Dose THCMFGMagstim Rapid 2 system triggering Magstim Super Rapid systemMagstim Rapid-2 system triggering Magstim Super Rapid systemMedicationsMindfulness Resiliency TrainingMitoQMusical InterventionN-acetylcysteineNaloxoneNaltrexoneNaltrexone 25mgNutritional Lifestyle Modification GroupPET ScanPF-03463275Person-centered planning (PCP)PhysostigminePimozide
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Aripiprazole
drugsmall molecule
Cannabidiol
drugsmall molecule
Olanzapine
drugsmall molecule
Quetiapine
drugsmall molecule
Risperidone
drugsmall molecule
Ziprasidone
drugsmall molecule
drug